CAR-T cells with the CD38-CD73-Tim-3-HLA-DR+ phenotype predict the efficacy of tisagenlecleucel as a treatment for B cell precursor ALL. - Mikami T; Kato I; Llamas-Covarrubias MA; Hiramatsu H; Uchihara Y; Mitsuyoshi T; Kitawaki T; Saida S; Umeda K; Ogawa S; Takaori-Kondo A; Wing JB; et al. (Cell reports. Medicine, 2026)